Diabetic and Nondiabetic Gastroparesis (Q40737151)

23 September 2017

Diabetic and Nondiabetic Gastroparesis (English)

1 reference

23 September 2017

McCallum RW

1

1 reference

PubMed ID

11096557

23 September 2017

Brown RL

series ordinal

2

1 reference

23 September 2017

1 December 1998

1 reference

Current treatment options in gastroenterology

23 September 2017

1 reference

23 September 2017

1

1 reference

23 September 2017

1

1 reference

23 September 2017

1-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s11938-998-0001-2

23 September 2017

0 references

cites work

Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment

1 reference

12 December 2020

The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders

1 reference

12 December 2020

Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

1 reference

12 December 2020

Acceleration of gastric emptying with electrical stimulation in a canine model of gastroparesis

1 reference

12 December 2020

Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Gastric pacing improves emptying and symptoms in patients with gastroparesis

1 reference

12 December 2020

Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Human gastric myoelectric activity and gastric emptying following gastric surgery and with pacing

1 reference

12 December 2020

1 reference

12 December 2020

Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders

1 reference

12 December 2020

Erythromycin and the gut.

1 reference

12 December 2020

Scintigraphic quantitation of gastrointestinal motor activity and transport: oesophagus and stomach

1 reference

12 December 2020

Effects of pacing parameters on entrainment of gastric slow waves in patients with gastroparesis.

1 reference

12 December 2020

Gastroparesis and the current use of prokinetic drugs.

1 reference

12 December 2020

Erythromycin and other macrolides as prokinetic agents

1 reference

12 December 2020

Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders

1 reference

12 December 2020

Gastroduodenal motility and dysmotility: an update on techniques available for evaluation.

1 reference

12 December 2020

The future of intestinal pacing

1 reference

12 December 2020

Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.

1 reference

12 December 2020

Effects of gastric pacing on canine gastric motility and emptying

1 reference

12 December 2020

Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis

1 reference

12 December 2020

10.1007/S11938-998-0001-2

Identifiers

DOI

1 reference

PubMed ID

11096557

Dimensions Publication ID

23 September 2017

0 references

1 reference

PubMed ID

11096557